BioTelemetry, CardioNet To Pay $44.8M To Settle FCA Case
By Gina Kim · December 20, 2022, 10:32 PM EST
Medical device manufacturer BioTelemetry and its subsidiary CardioNet have agreed to pay $44.8 million to resolve whistleblower claims accusing them of submitting fraudulent claims to federal health care programs for heart...
To view the full article, register now.